TSH and Free T4 should be checked at baseline and annually for everyone on tirzepatide
GLP-1 based therapies and disease course of inflammatory bowel disease
AstraZeneca Lead assets: Elecoglipron, an oral GLP-1RA candidate Metabolic focus: Obesity, overweight, type 2 diabetes and cardiometabolic disease AstraZeneca is developing elecoglipron as a once-daily GLP-1RA pill for obesity and type 2 diabetes
Pineal gland regulation: The tetrapeptide modulates melatonin synthesis in the pineal gland, potentially restoring age-related declines in melatonin production that contribute to disrupted circadian rhythms and reduced antioxidant defense
(4) From 1995 to 2014, the average amount of THC in marijuana has increased from 4 to 12 percent, says Staci Gruber, PhD, a professor of psychiatry at Harvard Medical School in Boston
Diabetes and endocrine disorders (hyperthyroidism/hypothyroidism) as risk factors for atrial fibrillation